Drug Type Small molecule drug |
Synonyms CGS 25248, CGS-25248, ZY 15119 + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18ClN3O3 |
InChIKeyQPKMIYNBZGPJAR-UHFFFAOYSA-N |
CAS Registry113957-09-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Cebaracetam | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition Disorders | Phase 2 | Switzerland | - | |
| Cognition Disorders | Phase 2 | - | - |





